The combination of the histone-deacetylase inhibitor trichostatin A and gemcitabine induces inhibition of proliferation and increased apoptosis in pancreatic carcinoma cells

International Journal of Oncology

Volumn 31, Issue 3, 2007, Pages 567-576

  Gahr, Susanne ^a   Ocker, Matthias ^a   Ganslmayer, Marion ^a   Zopf, Steffen ^a   Okamoto, Kinya ^a   Hartl, Andrea ^a   Leitner, Sandra ^a   Hahn, Eckhart G ^a   Herold, Christoph ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Bax; Caspase 8; Gemcitabine; Pancreatic cancer; Trichostatin A

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 8; DEOXYCYTIDINE; DRUG DERIVATIVE; GEMCITABINE; HYDROXAMIC ACID; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P21; TRICHOSTATIN A;

APOPTOSIS; ARTICLE; BIOSYNTHESIS; CARCINOMA; CELL PROLIFERATION; CELL SEPARATION; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; PANCREAS TUMOR; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA; CASPASE 3; CASPASE 8; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SEPARATION; DEOXYCYTIDINE; FLOW CYTOMETRY; HUMANS; HYDROXAMIC ACIDS; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS P21(RAS);

EID: 38449114690     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.31.3.567     Document Type: Article

References (21)

1. Society AC: Cancer Facts and Figures 2004. American Cancer Society, Atlanta, 2004.
2. Burris HA, III, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P, Nelson R, Dorr FA, Stephens CD and von Hoff DD: Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15: 2403-2413, 1997.
3. Shin JY, Kim HS, Lee KS, Kim J, Park JB, Won MH, Chae SW, Choi YH, Choi KC, Park YE and Lee JY: Mutation and expression of the p27KIP1 and p57KIP2 genes in human gastric cancer. Exp Mol Med 32: 79-83, 2000.
4. Herold C, Ganslmayer M, Ocker M, Hermann M, Geerts A, Hahn EG and Schuppan D: The histone-deacetylase inhibitor trichostatin A blocks proliferation and triggers apoptotic programs in hepatoma cells. J Hepatol 36: 233-240, 2002.
5. Schmidt K, Gust R and Jung M: Inhibitors of histone deacetylase suppress the growth of MCF-7 breast cancer cells. Arch Pharm 332: 353-357, 1999. (Pubitemid 29503296)
6. Csordas A: On the biological role of histone acetylation. Biochem J 265: 23-38, 1990.
7. Medina V, Edmonds B, Young GP, James R, Appleton S and Zalewski PD: Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): dependence on protein synthesis and synergy with a mitochondrial/cytochrome c-dependent pathway. Cancer Res 57: 3697-3707, 1997.
8. Gray SG, Kytola S, Lui WO, Larsson C and Ekstrom TJ: Modulating IGFBP-3 expression by trichostatin A: potential therapeutic role in the treatment of hepatocellular carcinoma. Int J Mol Med 5: 33-41, 2000.
9. Hoshikawa Y, Kwon HJ, Yoshida M, Horinouchi S and Beppu T: Trichostatin A induces morphological changes and gelsolin expression by inhibiting histone deacetylase in human carcinoma cell lines. Exp Cell Res 214: 189-197, 1994.
10. Piacentini P, Donadelli M, Costanzo C, Moore PS, Palmieri M and Scarpa A: Trichostatin A enhances the response of chemotherapeutic agents in inhibiting pancreatic cancer cell proliferation. Virchows Arch 448: 797-804, 2006.
11. Ocker M, Alajati A, Ganslmayer M, Zopf S, Luders M, Neureiter D, Hahn EG, Schuppan D and Herold C: The histone-deacetylase inhibitor SAHA potentiates proapoptotic effects of 5-fluorouracil and irinotecan in hepatoma cells. J Cancer Res Clin Oncol 131: 385-394, 2005.
12. Smiley ST, Reers M, Mottola-Hartshorn C, Lin M, Chen A, Smith TW, Steele GD Jr and Chen LB: Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Proc Natl Acad Sci USA 88: 3671-3675, 1991.
13. Mancini M, Anderson BO, Caldwell E, Sedghinasab M, Paty PB and Hockenbery D M: Mitochondrial proliferation and paradoxical membrane depolarization during terminal differentiation and apoptosis in a human colon carcinoma cell line. J Cell Biol 138: 449-469, 1997. (Pubitemid 27323545)
14. Legrand O, Perrot JY, Simonin G, Baudard M and Marie JP: JC-1: a very sensitive fluorescent probe to test Pgp activity in adult acute myeloid leukemia. Blood 97: 502-508, 2001.
15. Leers MP, Kolgen W, Bjorklund V, Bergman T, Tribbick G, Persson B, Bjorklund P, Ramaekers FC, Bjorklund B, Nap M, Jornvall H and Schutte B: Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis. J Pathol 187: 567-572, 1999.
16. Huang P, Chubb S, Hertel LW, Grindey GB and Plunkett W: Action of 2′,2′-difluorodeoxycytidine on DNA synthesis. Cancer Res 51: 6110-6117, 1991.
17. Jiang PH, Motoo Y, Sawabu N and Minamoto T: Effect of gemcitabine on the expression of apoptosis-related genes in human pancreatic cancer cells. World J Gastroenterol 12: 1597-1602, 2006.
18. Wang ZM, Hu J, Zhou D, Xu ZY, Panasci LC and Chen ZP: Trichostatin A inhibits proliferation and induces expression of p21WAF and p27 in human brain tumor cell lines. Ai Zheng 21: 1100-1105, 2002.
19. Park WH, Jung CW, Park JO, Kim K, Kim WS, Im YH, Lee MH, Kang WK and Park K: Trichostatin inhibits the growth of ACHN renal cell carcinoma cells via cell cycle arrest in association with p27, or apoptosis. Int J Oncol 22: 1129-1134, 2003.
20. Saito A, Yamashita T, Mariko Y, Nosaka Y, Tsuchiya K, Ando T, Suzuki T, Tsuruo T and Nakanishi O: A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors. Proc Natl Acad Sci USA 96: 4592-4597, 1999.
21. Gray SG and Ekstrom TJ: Effects of cell density and trichostatin A on the expression of HDAC1 and p57Kip2 in Hep 3B cells. Biochem Biophys Res Commun 245: 423-427, 1998.